| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.gianpathlabs.com | |
| Market Cap | 21.44 Cr. | |
| Enterprise Value(EV) | 22.90 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.03 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 20.05 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 66.90 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 16.57 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.25 | Calculated using Price: 20.73 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.03 Cr. | 10,341,527 Shares |
| FaceValue | 10 | |
| About Gian Life Care Ltd. | ||
| The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers various tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services. | ||
| 1 Day |
|
-0.34% |
| 1 Week |
|
+1.57% |
| 1 Month |
|
-16.38% |
| 3 Month |
|
-9.28% |
| 6 Month |
|
-2.31% |
| 1 Year |
|
-12.20% |
| 2 Year |
|
-33.88% |
| 5 Year |
|
|
| 10 Year |
|
| 1 years | 2022-03 | |
| Return on Equity (%) | 31.16 | |
| Return on Capital Employed (%) | 44.24 | |
| Return on Assets (%) | 18.95 |
| Particulars | 3 years | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 14 | 15 | 16 | |
| Non Curr. Liab. | 2 | 2 | 2 | |
| Curr. Liab. | 7 | 11 | 13 | |
| Minority Int. | ||||
| Equity & Liab. | 23 | 28 | 30 | |
| Non Curr. Assets | 13 | 17 | 18 | |
| Curr. Assets | 10 | 11 | 12 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 23 | 28 | 30 |
| Particulars | 2 years | 2022-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 16 | 10 | |
| Other Income | 1 | 1 | |
| Total Income | 16 | 11 | |
| Total Expenditure | -9 | -8 | |
| PBIDT | 7 | 3 | |
| Interest | -1 | 0 | |
| Depreciation | 0 | -1 | |
| Taxation | -1 | -1 | |
| Exceptional Items | |||
| PAT | 4 | 1 | |
| Minority Interest | |||
| Share Associate | |||
| Other Related Items | |||
| Consolidated Net Profit | 4 | 1 | |
| Adjusted EPS | 4 | 1 |
| Particulars | 1 years | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 6 | |
| Cash Fr. Inv. | -4 | |
| Cash Fr. Finan. | 1 | |
| Net Change | 2 | |
| Cash & Cash Eqvt | 5 |
|
Mon, 22 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Please find attached herewith Certificate under Regulation 74(5).For Gian Life Care Limited |
|
Tue, 02 Apr 2024
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 Please find attached herewith relevant disclosure under SEBI (PIT) regulations 2015.For Gian Life Care Limited |
|
Mon, 04 Mar 2024
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 Sir/ Maam Please find attached herewith disclosure as received by the Company under SEBI (PIT) Regulations 2015. |
| Mon, 22 Apr 2024 |
Opening at High
|
Closing Above Previous High
|
Close Within 52 Week Low Zone
|
High Decrease in 1 Month
|
Close Below Last Month Low
|
